What are appropriate interventions for a pt with systemic sclerosis who is now presenting with UGI discomfort?
Potential complications of esophageal disease in patients with systemic sclerosis include esophagitis, esophageal stricture, Barrett esophagus, and aspiration pneumonitis. Management of these conditions includes the use of prokinetic agents such as metoclopramide, erythromycin, and octreotide. In addition, gastric acid suppression with proton pump inhibitors is indicated for nearly all patients with systemic sclerosis. Patients with systemic sclerosis also have an increased risk for the development of Barrett esophagus, and screening for this condition is appropriate.